The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Xynos Konstantinos since 2023.
This trader's CIK number is 1956241.
At the time of last reporting, Xynos Konstantinos was the Chief Medical Officer of Replimune Group, Inc.. (stock ticker symbol REPL).
Also see all insider trading activities at Replimune Group, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | REPL | 0 | $0 | 7,952 | $64,093 | 0 | $0 |
2024 | REPL | 0 | $0 | 29,494 | $238,412 | 0 | $0 |
2023 | REPL | 0 | $0 | 8,084 | $93,773 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-20 | REPL | Sale | 7,952 | 8.06 | 64,093 |
2024-11-18 | REPL | Sale | 7,246 | 10.78 | 78,111 |
2024-06-07 | REPL | Sale | 15,881 | 7.50 | 119,107 |
2024-05-16 | REPL | Sale | 6,367 | 6.47 | 41,194 |
2023-11-16 | REPL | Sale | 7,313 | 10.92 | 79,857 |
2023-05-16 | REPL | Sale | 771 | 18.05 | 13,916 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Xynos Konstantinos (Chief Medical Officer of Replimune Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.